S&OP and Integrated Business Planning Excellence for Life Sciences 2027

23rd February 2027 - February 24, 2027

The Marcus Evans S&OP and Integrated Business Planning Excellence for Life Sciences conference will bring together pharmaceutical and medical device leaders to explore how organizations are evolving S&OP and IBP to address increasing supply chain complexity, market volatility, and changing business demands.

Through practical case studies, attendees will examine approaches to advancing S&OP maturity, improving demand signals, and strengthening scenario planning.

Sessions will focus on how organizations are embedding S&OP and IBP as a strategic enterprise-wide mechanism and leveraging AI to strengthen decision-making across functions.

Speakers include senior leaders from Johnson & Johnson Innovative Medicine, Novartis, GE Healthcare, Gilead Sciences, Bristol Myers Squibb, Galderma, Bayer and many more!

BioPharma Asia readers can benefit from a €200 discount! Enquire on our website for more registration information.

More Info